May 4, 2026 05:29PM
May 4, 2026 05:29PM
Apr 24, 2023 07:33PM
Nov 9, 2022 04:15PM
Sep 28, 2022 04:15PM
Sep 12, 2022 02:00AM
Sep 7, 2022 04:15PM NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer
May 18, 2022 09:12PM
May 18, 2022 04:40PM
Jan 5, 2022 04:15PM
Sep 8, 2021 04:15PM
Apr 28, 2021 04:15PM
Mar 17, 2021 05:15PM
Feb 26, 2021 04:15PM NANOBIOTIX 2020 Q4 and Annual Revenues
Jan 8, 2021 08:00AM
Jan 8, 2021 02:00AM
Nov 17, 2020 02:00AM
Oct 26, 2020 03:00AM
Oct 13, 2020 02:00AM
Sep 4, 2020 12:00PM
Jul 17, 2020 12:20PM Nanobiotix Announces Revenue for Second Quarter 2020 and First Half Year 2020
Jun 30, 2020 01:17AM
Jun 29, 2020 01:41AM
Jun 17, 2020 01:00PM
May 29, 2020 12:02PM
May 26, 2020 01:12AM
May 6, 2020 01:00PM
Apr 30, 2020 01:19PM NANOBIOTIX Announces First Quarter 2020 Revenues
Apr 21, 2020 02:00AM
Apr 1, 2020 11:27AM
Mar 17, 2020 04:25PM
Mar 9, 2020 03:01PM
Feb 26, 2020 11:14AM
Feb 10, 2020 02:39PM
Jan 7, 2020 02:04PM NANOBIOTIX Announces Plan for Global Phase III Head and Neck Cancer Registration Trial Along With Overall Development Update
Dec 16, 2019 03:00PM
Nov 12, 2019 01:30AM
Sep 18, 2019 03:55PM
Sep 4, 2019 01:00PM
Jul 9, 2019 02:50PM
Jul 9, 2019 02:45PM
Jun 4, 2019 02:00AM NANOBIOTIX APPOINTS NEW CHIEF MEDICAL OFFICER AS THE COMPANY EVOLVES AFTER ACHIEVEMENT OF EUROPEAN MARKET APPROVAL
Jun 4, 2019 02:00AM
Apr 30, 2019 01:22PM
Apr 4, 2019 12:31PM
Apr 2, 2019 12:56PM
Mar 26, 2019 03:07AM
Mar 26, 2019 03:00AM
Mar 15, 2019 02:12PM Nanobiotix 2018 Annual Results
Mar 15, 2019 01:40PM

328,812 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All